 |
市場調查報告書
商品編碼
1529556
冷凍乾燥藥品市場：按藥物類別、按適應症、按包裝類型、按分銷管道、按地區Lyophilized Drugs Market, By Drug Class, By Indication, By Packaging Type, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計2024年全球凍乾藥品市場規模為3,401.1億美元，預計2031年將達6,181億美元，2024年至2031年複合年成長率為8.9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 3401.1億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 2024-2031 年預測期複合年成長率 | 8.90% | 2031 年金額預測 | 6181億美元 |
圖：凍乾藥品市場的區域佔有率（%）（2024 年）
推動全球凍乾藥品市場成長的是與藥品凍乾相關的各種好處，例如提高穩定性、易於給藥和降低運輸成本。冷凍乾燥可以去除配方中的水分，防止微生物生長，有助於延長藥品的保存期限。也可以在不冷藏的情況下儲存和運輸藥品。由於慢性病的增加以及製藥公司對新型藥物輸送解決方案的研發投資增加，預計在預測期內對冷凍乾燥藥品的需求將大幅增加。
市場動態：
全球凍乾藥品市場的推動因素包括老年人口的增加、慢性病盛行率的上升以及凍乾藥品的優點（例如更長的保存期限和更低的微生物污染風險）。然而，與冷凍乾燥設備和程序相關的高成本預計將限制市場成長。另一方面，由於醫療基礎設施的改善和醫療支出的增加，預計亞太和拉丁美洲新興市場將為市場參與企業提供利潤豐厚的機會。此外，對新穎且更高效的冷凍乾燥技術的市場開拓的持續研究預計將在預測期內進一步為全球市場擴張創造機會。
本研究的主要特點
- 本報告對全球凍乾藥品市場進行了詳細分析，包括以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。 。
- 它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
- 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球凍乾藥品市場的主要企業。
- 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
- 全球凍乾藥品市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 相關人員可以透過用於全球凍乾藥品市場分析的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行概述
- 一致的機會地圖 (COM)
第3章 市場動態、法規與趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球凍乾藥品市場 - 冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球凍乾藥品市場，依藥品類別，2019-2031（十億美元）
- 介紹
- 抗感染
- 抗癌藥物
- 利尿劑
- 質子幫浦抑制劑
- 麻醉劑
- 抗凝血物
- NSAID
- 其他
第6章全球凍乾藥品市場，依包裝類型，2019-2031（十億美元）
- 介紹
- 管瓶
- 注射
- 墨水匣
第7章全球凍乾藥品市場，依通路，2019-2031（十億美元）
- 介紹
- 醫院藥房
- 零售藥房
- 網路藥房
第8章 全球凍乾藥品市場，依適應症分類，2019-2031 年（十億美元）
- 介紹
- 腫瘤學
- 感染疾病
- 自體免疫疾病
- 消化系統疾病
- 皮膚病
- 呼吸系統疾病
- 眼科疾病
- 荷爾蒙失調
- 其他
第9章2019-2031年全球凍乾藥品市場（按地區）（十億美元）
- 介紹
- 拉丁美洲
- 歐洲
- 亞太地區
- 波灣合作理事會
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第10章競爭格局
- 公司簡介
- Pfizer Inc.
- Novartis AG
- Roche Holding AG
- Johnson &Johnson
- Sanofi SA
- Amgen Inc.
- AbbVie Inc.
- Merck &Co., Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- Bristol Myers Squibb Company
- GlaxoSmithKline plc
- Gilead Sciences, Inc.
- Biogen Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Celgene Corporation
- Novo Nordisk A/S
- Vertex Pharmaceuticals Incorporated
- Takeda Pharmaceutical Company Limited
第11章分析師建議
- 上升和下降
- 綜合機會圖
第12章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI2930
The global lyophilized drugs market is estimated to be valued at USD 340.11 Bn in 2024 and is expected to reach USD 618.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 340.11 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.90% | 2031 Value Projection: | US$ 618.10 Bn |
Figure. Lyophilized Drugs Market Share (%), By Region 2024
The global lyophilized drugs market growth is driven by various advantages associated with lyophilization of drugs such as improved stability, ease of administration, and reduced transportation costs. Lyophilization or freeze-drying helps extend the shelf life of drugs by removing water from the formulations, thereby preventing the growth of microorganisms. It also enables storage and transportation of drugs without refrigeration. With the growing prevalence of chronic diseases and increasing R&D investments of pharmaceutical companies in novel drug delivery solutions, the demand for lyophilized drugs is expected to rise substantially during the forecast period.
Market Dynamics:
The global lyophilized drugs market is driven by the growing geriatric population, rising incidence of chronic diseases, and advantages of lyophilized drugs such as longer shelf life and lower risk of microbial contamination. However, high costs associated with lyophilization equipment and procedures are expected to restrain the market growth. On the other hand, emerging markets of Asia Pacific and Latin America are likely to offer lucrative opportunities for market players owing to improving healthcare infrastructure and increasing healthcare spending in these regions. Additionally, ongoing research for development of novel and more efficient lyophilization technologies will further create opportunities for the expansion of the global market during the forecast period.
Key Features of the Study:
- This report provides in-depth analysis of the global lyophilized drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global lyophilized drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc., Baxter International Inc., Jadavpur University, Merck & Co., Inc., and GlaxoSmithKline plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lyophilized drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lyophilized drugs market
Detailed Segmentation-
- By Drug Class
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- By Indication
- Oncology
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Dermatological Disorders
- Respiratory Diseases
- Ophthalmic Diseases
- Hormonal Disorders
- Others
- By Packaging Type
- Vial
- Injection
- Cartridge
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Pfizer Inc.
- Novartis AG
- Roche Holding AG
- Johnson & Johnson
- Sanofi S.A.
- Amgen Inc.
- AbbVie Inc.
- Merck & Co., Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- Bristol Myers Squibb Company
- GlaxoSmithKline plc
- Gilead Sciences, Inc.
- Biogen Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Celgene Corporation
- Novo Nordisk A/S
- Vertex Pharmaceuticals Incorporated
- Takeda Pharmaceutical Company Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Indication
- Market Snapshot, By Packaging Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Lyophilized Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Lyophilized Drugs Market, By Drug Class, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Anti-infective
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antineoplastic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diuretics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Proton Pump Inhibitor
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Anesthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Anticoagulant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- NSAID's
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Lyophilized Drugs Market, By Packaging Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Vial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cartridge
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Lyophilized Drugs Market, By Distribution Channel , 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Lyophilized Drugs Market, By Indication, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infectious Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Autoimmune Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Gastrointestinal Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Dermatological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ophthalmic Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hormonal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Lyophilized Drugs Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Roche Holding AG
- Johnson & Johnson
- Sanofi S.A.
- Amgen Inc.
- AbbVie Inc.
- Merck & Co., Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- Bristol Myers Squibb Company
- GlaxoSmithKline plc
- Gilead Sciences, Inc.
- Biogen Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Celgene Corporation
- Novo Nordisk A/S
- Vertex Pharmaceuticals Incorporated
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
